These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
735 related items for PubMed ID: 26826308
1. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. Byeon HJ, Thao le Q, Lee S, Min SY, Lee ES, Shin BS, Choi HG, Youn YS. J Control Release; 2016 Mar 10; 225():301-13. PubMed ID: 26826308 [Abstract] [Full Text] [Related]
2. Lactoferrin-modified poly(ethylene glycol)-grafted BSA nanoparticles as a dual-targeting carrier for treating brain gliomas. Su Z, Xing L, Chen Y, Xu Y, Yang F, Zhang C, Ping Q, Xiao Y. Mol Pharm; 2014 Jun 02; 11(6):1823-34. PubMed ID: 24779677 [Abstract] [Full Text] [Related]
3. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Thao le Q, Byeon HJ, Lee C, Lee S, Lee ES, Choi YW, Choi HG, Park ES, Lee KC, Youn YS. Pharm Res; 2016 Mar 02; 33(3):615-26. PubMed ID: 26526555 [Abstract] [Full Text] [Related]
4. A novel prototype of albumin nanoparticles fabricated by supramolecular cyclodextrin-adamantane association. Lee S, Lee C, Kim B, Thao LQ, Lee ES, Kim JO, Oh KT, Choi HG, Youn YS. Colloids Surf B Biointerfaces; 2016 Nov 01; 147():281-290. PubMed ID: 27522557 [Abstract] [Full Text] [Related]
5. Exploiting macrophages as targeted carrier to guide nanoparticles into glioma. Pang L, Qin J, Han L, Zhao W, Liang J, Xie Z, Yang P, Wang J. Oncotarget; 2016 Jun 14; 7(24):37081-37091. PubMed ID: 27213597 [Abstract] [Full Text] [Related]
6. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC. Int J Pharm; 2011 Jan 17; 403(1-2):285-91. PubMed ID: 21035530 [Abstract] [Full Text] [Related]
7. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Min SY, Byeon HJ, Lee C, Seo J, Lee ES, Shin BS, Choi HG, Lee KC, Youn YS. Int J Pharm; 2015 Oct 15; 494(1):506-15. PubMed ID: 26315118 [Abstract] [Full Text] [Related]
8. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. Li W, Yi X, Liu X, Zhang Z, Fu Y, Gong T. J Control Release; 2016 Mar 10; 225():170-82. PubMed ID: 26826304 [Abstract] [Full Text] [Related]
9. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands. Wei X, Gao J, Zhan C, Xie C, Chai Z, Ran D, Ying M, Zheng P, Lu W. J Control Release; 2015 Nov 28; 218():13-21. PubMed ID: 26428462 [Abstract] [Full Text] [Related]
11. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers. Geldenhuys W, Wehrung D, Groshev A, Hirani A, Sutariya V. Pharm Dev Technol; 2015 Jun 28; 20(4):497-506. PubMed ID: 24597667 [Abstract] [Full Text] [Related]
16. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y, Liang L, Wang X, Wang J, Zhang X, Zhang Q. J Control Release; 2011 Jun 30; 152(3):402-10. PubMed ID: 21435361 [Abstract] [Full Text] [Related]
17. Doxorubicin-loaded human serum albumin nanoparticles surface-modified with TNF-related apoptosis-inducing ligand and transferrin for targeting multiple tumor types. Bae S, Ma K, Kim TH, Lee ES, Oh KT, Park ES, Lee KC, Youn YS. Biomaterials; 2012 Feb 30; 33(5):1536-46. PubMed ID: 22118776 [Abstract] [Full Text] [Related]